Authors


Daniel R. Verdon

Latest:

Biosimilars: Some Call for ‘Cautious Optimism’

Biosimilars may need more time to devleop in the market.


Rachael Zimlich, RN, BSN

Latest:

Combined Influenza, COVID-19 Vaccines Offer Strongest Protection for Children

While either vaccine offers some protection, having both vaccines offers the strongest level of protection against hospitalization and severe complications like MIS-C, and death.


Frederick S. Mayer, PharmD, MPH

Latest:

Beware of fake remedies sold as "dietary supplements"

Manufacturers, promoters, and sellers of dietary supplements are prohibited by law from making claims to treat or cure illness or disease, or their symptoms. Pharmacists should encourage patients to check with medical professionals before commencing use of any dietary supplement.


Tricia Krizner

Latest:

Generics of Older Drugs Could Have Saved Medicare Billions, Study Says

Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.


Clipper Young, PharmD Candidate

Latest:

DXM and the threat to public health

Teens are using OTC cough syrup, with DXM as an active ingredient, to get high. While the drug may be legal, its harmful effects are similar to those of illegal drugs.


Allison Tsai, Associate Editor, Centralized Content Group

Latest:

Medicare Part D: Community CCRX offers incentives to pharmacies

Only one Medicare Part D prescription plan operates in partnership with pharmacists: Community CCRx, which offers incentives for generic dispensing, therapy management, and maintenance supply fills. More than 63,000 pharmacies across the country participate in the program, including all major chains and community pharmacies.


T. Joseph Mattingly II, PharmD student

Latest:

Can you explain pharmacy to an eighth grader?

Pharmacists should spread the word that they are the medication experts.


Margaret Mulligan, BA, BSN, RN, Editor-in-Chief

Latest:

Walgreens opens 7,000th store in Brooklyn, New York

On October 1, the 7,000th Walgreens store opened in Brooklyn, N.Y., amid festivities that included free health screenings and speeches from Walgreens CEO Greg Wasson and Borough President Marty Golden.


David Bennett, Senior Editor

Latest:

Pharmacists hope 2009 will be a good year for business

Despite challenges from a contracting economy, pharmacists are optimistic about 2009.


Mari Edlin

Latest:

Pharmacy Technology: Disruption or Improvement?

Is new technology actually making pharmacy any better (or easier)?


Barbara L. Hesselgrave

Latest:

World AIDS Conference 2012 seeks an AIDS-free generation

This year's International AIDS Conference looked toward a generation free of AIDS.


Aleksandr Domovich, PharmD candidate

Latest:

Viewpoint: Should an RX label require a use-by date or an expiration date?

All prescription drugs should have a sell-by date for consistency and patient protection.


Kathy Method, Clinical Senior Editor, Centralized Content Group

Latest:

Going, going, gone

Over the next several years, generic versions of many best-selling drugs will become available as patents reach their expiration dates.


Joel Claycomb, PharmD

Latest:

Drug donations in humanitarian aid: A mixed blessing

In disaster relief, inappropriate pharmaceutical donations and/or a disorganized receiving operation can mean that tons of medications go straight into the rubbish.


Amanda Brower, Senior Editor, Centralized Content Group

Latest:

Retail pharmacists, store managers can learn from each other

The retail pharmacist who runs a pharmacy inside a big-box store can improve departmental operations by understanding the point of view of the retail store manager. Although pharmacist and manager have different focuses and priorities, they can work together to improve delivery of services when they understand each other's needs.


Ned Milenkovich, PharmD, JD

Latest:

Federal track and trace legislation imminent

The bicameral legislation provides specific requirements for all stakeholders in the drug-distribution supply chain, including manufacturers, wholesalers, repackagers, and pharmacies.


Jim Plagakis, RPh

Latest:

Late at night and over the line

An encounter with a police officer reminds JP that the world sees pharmacists only as pill counters.


Stacy R. Foltz, PharmD

Latest:

Some Lyme patients need long-term drugs

This is the story of my bout with Lyme disease and what a harrowing experience it's been. I hope that by telling my story, I can help you learn from my experience and apply it to your practice.


John Yuscavage, RPh

Latest:

Rx Puzzler: Hello, is Les there?

Welcome to the first installment of our new column, Rx Puzzler.


Felicia Duffy, RN, BSN, MSEd

Latest:

FDA Safety Page: Helping patients understand OTC labeling

The FDA recommends that you counsel patients on the importance of reading product labels carefully to determine the active ingredients and dosing instructions of each product and to discourage them from making assumptions about use based on product names or appearance. The use of similar trade names (so-called "brand-name families") is common practice for OTC products. The products with the trade names "Sudafed" and "Sudafed PE" illustrate specific concerns.


Stan Illich, RPh, MHA

Latest:

Where to from here? Pharmacy's evolving options

In this month's DT Blog post, contributor Stan Illich outlines some innovations that could strengthen the practice of pharmacy, benefit patients, and assist providers. Now, if we can just work out the bottom line . . .


James E. Waun, MD, MA, RPh

Latest:

Pharmacy 2008: A day in the life

21st century pharmacy: Everyone's frustrated and services suffer.


Sara Schilit, PharmD

Latest:

Viewpoint: Should an RX label require a use-by date or an expiration date?

All prescription drugs should have a sell-by date for consistency and patient protection.



Kenneth R. Baker, BS Pharm, JD

Latest:

How to Protect Yourself from Red Flags

Why pharmacists need to be paying attention to the Trinity II case and its consequences.


Craig I. Coleman, PharmD

Latest:

New treatments for obesity and OAB

FDA approves Lorcaserin and Mirabegron extended-release tablets.



Maude L. Campbell

Latest:

Cardiometabolic disorders: The pharmacist's role

The term "cardiometabolic disorders" (CMD) refers to a cluster of interrelated risk factors (hypertension, elevated fasting glucose, reduced high-density lipoprotein, elevated triglycerides, and abdominal obesity) that promote the development of atherosclerotic cardiovascular disease and type 2 diabetes. With an estimated 47 million Americans facing increased risk of heart disease because of these conditions, management of patients' CMD is a priority for pharmacists.


Alaina Scott, Senior Editor

Latest:

Supply of heparin further secured

A second round of revised quality standards for heparin became effective recently, the U.S. Pharmacopeial (USP) Convention has announced.


Oluwole Williams, BPharm, PharmD

Latest:

Mentors, peer review, and the oath of a pharmacist

Professions survive and prosper when mentors and their juniors embrace one another respectfully and cooperatively for the progressive promotion of their vocation. In this way, the seniors would not carry their valuable professional experience to their graves, and the juniors would not commit irreparable blunders as they enter the stage of practice.

© 2024 MJH Life Sciences

All rights reserved.